Tyler Robson

CEO & Director
Board Member & Executive Team Member

Based on Mr. Robson’s impressive commitment and contributions to Valens GroWorks, he was appointed CEO in May 2017 after previously serving as Chief Operating Officer. Tyler attended the University of Saskatchewan on a football scholarship, graduating with a Bachelor of Science degree. He returned to Kelowna to pursue his passion for the cannabis industry by focusing on research and development, plant innovation, and life sciences. Tyler’s main interest is the medical application of cannabis to combat ailments while preparing for the up and coming adult use recreational market.

John Cullen

Board Member

Mr. Cullen is a Co-Founder, Director and CEO of JHI Associates Inc. a private oil and gas exploration company with significant acreage in the deepwater offshore Guyana, South America. Mr. Cullen has over 30 years’ experience in public company financing, corporate / capital structuring and management. Following 15 years in the Canadian investment brokerage industry, Mr. Cullen founded a number of private and public companies in the international resource sector. He brings significant boardroom and executive experience to his role as a director of Valens.

Dave Gervais

Director & Co-Founder of Valens Agritech
Board Member

Mr. Gervais has been extensively involved in the medicinal cannabis sector for over 17 years, acquiring a wealth of cannabis related experience, knowledge, and expertise. Before founding Valens Agritech Ltd., Mr. Gervais was president of Northwest Supplements, a pharmaceutical wholesale company that specialized in international importing and exporting.

Rob O’Brien, Ph.D.

CSO of Valens Groworks Corp.
Board Member & Executive Team Member

Dr. O’Brien was a professor in Analytical Chemistry for over 13 years and has more than 25 years of experience in analytical chemistry. An expert in analytical instrumentation, he has set up a number of advanced analytical laboratories and has held an executive position in a number of commercial enterprises. Dr. O’Brien possesses a track record of successful commercialization of intellectual property developed from academic research. Dr O’Brien is currently a director of both Valens subsidiaries (Valens Agritech Ltd. and Supra THC Services Inc.)

Scott Young

Business Development & Investor Relations
Executive Team Member

Mr. Young’s focus at Valens is corporate finance initiatives. Mr. Young has spent the past 15 years working in the capital market sectors of Canada, the United States and Europe. Beyond this, he has extensive business development experience in Hong Kong, North and South America. He has helped finance numerous start-up companies through his networks in energy, mining, technology and biotechnology. His expertise in financing, marketing and communications help profile VGW to retail and institutional investors globally.